Serum C - Reactive Protein Level as a Predictor of New-Onset Postoperative Atrial Fibrillation in Off-Pump Coronary Artery Bypass Grafting
DOI:
https://doi.org/10.70749/ijbr.v3i7.1896Keywords:
Serum C - Reactive Protein Level, Postoperative atrial fibrillation, POAF, coronary artery bypass grafting proceduresAbstract
Background: Postoperative atrial fibrillation (POAF) complicates up to 30% of coronary artery bypass grafting procedures and is linked to prolonged hospitalization, increased stroke risk, and higher mortality. Although off‑pump CABG (OPCAB) avoids cardiopulmonary bypass–induced inflammation, POAF remains common, suggesting that even minimal surgical trauma provokes an inflammatory environment sufficient to trigger arrhythmia. Serum C‑reactive protein (CRP) is an inexpensive, readily available marker of systemic inflammation; if elevated early after surgery, it may identify patients at higher arrhythmic risk and thus guide targeted prophylaxis. Methods: In this analytical cross‑sectional study, 100 consecutive OPCAB patients (age 35–70 years) were enrolled at the Armed Forces Institute of Cardiology/NIHD, Rawalpindi. Daily serum CRP was measured from postoperative day (POD) 0 through POD5. Patients were stratified into two groups CRP < 10 mg/L versus CRP ≥ 10 mg/L based on the operational definition of elevated inflammation. Continuous ECG monitoring and daily 12‑lead ECGs identified new‑onset POAF (absence of P waves, irregular RR intervals) within five days. Multivariate logistic regression adjusted for hypertension, diabetes, albumin level, and other confounders. Results: POAF incidence was significantly higher in the elevated‑CRP group (36% vs. 14%, p=0.02). After adjustment, CRP ≥ 10 mg/L conferred a 1.29‑fold increased odds of POAF (95% CI: 1.09–1.52; p=0.03), hypertension a 4.7‑fold increase (p=0.02), and hypoalbuminemia a protective but clinically counterintuitive association (aOR 0.05; p=0.01), likely reflecting complex nutritional–inflammatory interactions. Receiver‑operator characteristic analysis yielded an AUC of 0.68 for CRP (cut‑off 10 mg/L), with 72% sensitivity and 57% specificity, underscoring moderate discrimination. Conclusion and Implications: Elevated early postoperative CRP independently predicts POAF in OPCAB patients, affirming the causal role of surgical inflammation in arrhythmogenesis. Although CRP alone offers moderate accuracy, its routine measurement could flag high‑risk individuals for intensified monitoring, anti‑inflammatory prophylaxis (e.g., colchicine, statins), or early antiarrhythmic therapy. Integrating CRP into multifactorial risk models may enhance personalized perioperative care and ultimately reduce the burden of POAF.
Downloads
References
1. Taha A, Martinsson A, Nielsen SJ, Rezk M, Pivodic A, Gudbjartsson T, et al. New-onset atrial fibrillation after coronary surgery and stroke risk: a nationwide cohort study. Heart (British Cardiac Society). 2024;111(1):18-26.
https://doi.org/10.1136/heartjnl-2024-324573
2. Zhou JY, Zhang JL, Xi L, Guo ZP, Liu XC, Liu ZG, et al. Risk Factors of Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery in the Recent 10 Years: Clinical Analysis of 6229 Patients. Clinical cardiology. 2024;47(10):e24335.
https://doi.org/10.1002/clc.24335
3. Mittal S, Bhushan R, Jhajhria N, Aiyer PV, Grover V. The Significance of Systemic Inflammatory Markers in 'New-Onset Atrial Fibrillation' Following Cardiac Surgeries. Cureus. 2024;16(5):e59869.
https://doi.org/10.7759/cureus.59869
4. Yuksel A, Velioglu Y, Atasoy MS, Muduroglu A, Gurbuz O, Aldemir M, et al. Multi-inflammatory index as a novel predictor of new-onset atrial fibrillation after off-pump coronary artery bypass grafting. Kardiologia polska. 2024;82(7-8):733-40.
https://doi.org/10.33963/v.phj.100847
5. Oraii A, Masoudkabir F, Pashang M, Jalali A, Sadeghian S, Mortazavi SH, et al. Effect of postoperative atrial fibrillation on early and mid-term outcomes of coronary artery bypass graft surgery. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2022;62(3).
https://doi.org/10.1093/ejcts/ezac264
6. Musa AF, Dillon J, Taib MEM, Yunus AM, Sanusi AR, Nordin MN, et al. Incidence and Outcomes of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting of a Randomized Controlled Trial: A Blinded End-of-cycle Analysis. Reviews in cardiovascular medicine. 2022;23(4):122.
https://doi.org/10.31083/j.rcm2304122
7. Feilberg Rasmussen L, Andreasen JJ, Riahi S, Lundbye-Christensen S, Johnsen SP, Andersen G, et al. Risk and Subtypes of Stroke Following New-Onset Postoperative Atrial Fibrillation in Coronary Bypass Surgery: A Population-Based Cohort Study. Journal of the American Heart Association. 2022;11(24):e8032.
https://doi.org/10.1161/jaha.122.027010
8. Squiccimarro E, Lorusso R, Consiglio A, Labriola C, Haumann RG, Piancone F, et al. Impact of Inflammation After Cardiac Surgery on 30-Day Mortality and Machine Learning Risk Prediction. Journal of cardiothoracic and vascular anesthesia. 2025;39(3):683-91.
https://doi.org/10.1053/j.jvca.2024.12.013
9. Luo M. Systemic inflammation and cardiac surgery: insights from the RECCAS trial. Critical care (London, England). 2025;29(1):1.
https://doi.org/10.1186/s13054-024-05230-5
10. Imazio M, Trinchero R, Brucato A, Rovere ME, Gandino A, Cemin R, et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31(22):2749-54.
https://doi.org/10.1093/eurheartj/ehq319
11. Abbasciano RG, Tomassini S, Roman MA, Rizzello A, Pathak S, Ramzi J, et al. Effects of interventions targeting the systemic inflammatory response to cardiac surgery on clinical outcomes in adults. The Cochrane database of systematic reviews. 2023;10(10):Cd013584.
https://doi.org/10.1002/14651858.cd013584.pub2
12. Lee Y, Im S, Kang Y, Sohn SH, Jang MJ, Hwang HY. Impact of perioperative high-intensity statin treatment on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting: a meta-analysis. Acute and critical care. 2024;39(4):507-16.
https://doi.org/10.4266/acc.2024.00633
13. Brunetta E, Del Monaco G, Rodolfi S, Zachariah D, Vlachos K, Latini AC, et al. Incidence and predictors of post-surgery atrial fibrillation occurrence: A cohort study in 53,387 patients. Journal of arrhythmia. 2024;40(4):815-21.
https://doi.org/10.1002/joa3.13058
14. Gür AK, Aykac MC, Sisli E. The Effects of Serum CRP Level on Postoperative Atrial Fibrilation Occurrence in Patients who had Coronary Bypass Surgery. East J Med. 2018;23(4):284-8.
https://doi.org/10.5505/ejm.2018.92053
15. Mekonen Gdey M, Buch P, Pareesa F, Thorani M, Nasser H, Bandaru RR, et al. Predictors of Developing Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft: A Systematic Review and Meta-Analysis. Cureus. 2023;15(12):e51316.
https://doi.org/10.7759/cureus.51316
16. Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). European Heart Journal. 2024;45(36):3314-414.
https://doi.org/10.1093/eurheartj/ehaf079
17. Members: ATF, Jeppsson A, Rocca B, Hansson EC, Gudbjartsson T, James S, et al. 2024 EACTS Guidelines on perioperative medication in adult cardiac surgery. European Journal of Cardio-Thoracic Surgery. 2024;67(1).
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.